Los Angeles Capital Management’s Agilon Health AGL Stock Holding History

Los Angeles Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-649	Closed	-$37.3K	–	1350
2025 Q2	$37.3K	Sell	649 -4,570	-88%	-$367K	﹤0.01%	1319
2025 Q1	$565K	Sell	5,219 -7	-0.1%	-$609	﹤0.01%	718
2024 Q4	$248K	Buy	5,226 +2	+0%	+$121	﹤0.01%	993
2024 Q3	$513K	Buy	+5,224	New	+$675K	﹤0.01%	857
2023 Q1	–	Sell	-3,336	Closed	-$1.35M	–	1155
2022 Q4	$1.35M	Sell	3,336 -3,282	-50%	-$1.54M	0.01%	621
2022 Q3	$3.88M	Buy	6,618 +2,269	+52%	+$1.36M	0.02%	395
2022 Q2	$2.37M	Buy	+4,349	New	+$2.2M	0.01%	497

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Los Angeles Capital Management's AGL Position: Q3 2025 in Review

Los Angeles Capital Management sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 649 shares — an estimated $37.3K sold.

Los Angeles Capital Management first reported a position in AGL in Q2 2022 and held it in 7 quarters. The position peaked at $3.88M in Q3 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

Los Angeles Capital Management reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
Los Angeles Capital Management sold 649 Agilon Health shares in Q3 2025, an estimated $37.3K.
Los Angeles Capital Management first reported a position in Agilon Health in Q2 2022 and held it in 7 quarters.
Los Angeles Capital Management's Agilon Health position peaked at $3.88M in Q3 2022.
190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.